Angelin B
Department of Medicine, Karolinska Institutet, Huddinge University Hospital, Stockholm, Sweden.
Eur J Clin Pharmacol. 1989;37(1):95-6. doi: 10.1007/BF00609433.
An increased incidence of cholecystitis has been observed in thiazide-treated patients. In order to test the possibility that the therapy might have caused an increase in the cholesterol saturation of gallbladder bile, biliary lipid composition was determined in fasting duodenal bile obtained from 10 healthy individuals after cholecystokinin injection, before and after 3 weeks of treatment with hydrochlorthiazide. The mean relative concentration of cholesterol was increased in 6 subjects, from 4.7 to 5.6 mol%, and the cholesterol saturation of bile was increased in 7, from 69 to 81%. These preliminary results indicate that thiazide treatment may to some extent increase biliary cholesterol saturation, and this may, at least in part, explain the higher prevalence of symptomatic gallbladder disease during such therapy.
在接受噻嗪类治疗的患者中,胆囊炎的发病率有所增加。为了检验该治疗可能导致胆囊胆汁胆固醇饱和度升高的可能性,对10名健康个体在注射胆囊收缩素后、服用氢氯噻嗪3周前后获取的空腹十二指肠胆汁中的胆汁脂质成分进行了测定。6名受试者的胆固醇平均相对浓度从4.7摩尔%升至5.6摩尔%,7名受试者的胆汁胆固醇饱和度从69%升至81%。这些初步结果表明,噻嗪类治疗可能在一定程度上增加胆汁胆固醇饱和度,这可能至少部分解释了该治疗期间有症状胆囊疾病的较高患病率。